BMJ
Khoáng sản Miền Đông AHP ·UPCOM ·2026Q1
▲▲ Improving positively
TTM · Applied to: EPS, ROE, ROA, Net Margin, Asset Turnover, Debt/Equity
What Is Changing
On a TTM 2026Q1 basis, BMJ has not accelerated revenue sharply, but profitability is improving visibly — profit is at an all-time high. However, operating cash flow is significantly negative relative to profit — this needs monitoring in coming periods.
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 131.8 | 92.5 | 207.5 | 201.5 | 115.4 | 228.2 | 132.0 | 111.9 | 63.0 | 115.7 | 132.1 | 110.4 |
| Growth | +42% | -55% | +3% | +75% | -49% | +73% | +18% | +78% | -46% | -12% | +20% | — |
| Net Income | 11.1 | 45.0 | 15.3 | 24.1 | 12.3 | 11.7 | 10.8 | 17.7 | 8.3 | 12.0 | 11.9 | 18.4 |
| Net Margin | 8.41% | 48.58% | 7.36% | 11.97% | 10.64% | 5.13% | 8.20% | 15.82% | 13.22% | 10.39% | 9.03% | 16.67% |
Drivers of BMJ's profit
Net profit attributable to parent increased vs last year, mainly helped by higher gross profit. Supporting and offsetting drivers:
Net profit attributable to parent declined vs prior quarter, mainly due to lower financial income. Supporting and offsetting drivers:
Financial Highlights
Detailed analysis of each financial dimension
ROE = Profit Margin × Asset Turnover × Equity Multiplier
ROE rose from 4.4% to 7.2% — mainly driven by net margin, despite asset turnover moving in the opposite direction.
Is the profit sustainable?
Accounting profit is positive but operating cash flow has not caught up — needs more time to confirm.
What is driving the margin?
Net margin expanded to 15.07%, rising 6.1pp. The main driver is Gross margin rose 5.4pp, moving in line with the stronger net margin (with additional support from Net financial result / Revenue rose 1.1pp and Other profit / Revenue rose 0.6pp).
The improvement comes from core operations — this is a high-quality margin expansion.
Profitability trend
TTM YoY · 2025Q1 -> 2026Q1
Is capital being used efficiently?
Return on capital rose, but cash cycle lengthened by 74.0 days — working capital needs watching.
Is capital being deployed efficiently?
ROIC expanded to 5.78%, rising 2.0pp. That translates to 5.78 in after-tax operating profit for every 100 units of operating capital. The main driver is NOPAT margin rose 5.6pp, with capital turnover broadly stable; while invested capital rose by 192bn.
NOPAT margin is the main cushion preventing ROIC from slipping as invested capital keeps expanding — the quality of this improvement depends on whether margin holds once the new capital is fully deployed.
CAPITAL EFFICIENCY TREND
TTM YoY · 2025Q1 -> 2026Q1
Balance Sheet
ROIC is improving — the asset structure below shows how capital is being allocated. Capital structure is conservative with low leverage — liabilities at 0.34x equity, net debt at 0.25x equity.
Inventory ended the period at 308.4bn, roughly 16.4% of total assets.
Over the last 12 months, working capital absorbed 150.3bn of cash, mainly because of higher inventories and lower payables. Part of that drag was offset by lower receivables.
Working Capital Drivers
TTM YoY · 2025Q1 -> 2026Q1
Working Capital Efficiency
Cash conversion cycle lengthened by 74.0 days versus the same period last year. The main moves came from DIO rose 62.6 days, DSO rose 2.2 days, and DPO fell 9.2 days.
All 3 drivers are deteriorating — working capital is becoming more deeply tied up in the operating cycle.
Watchpoints
CCC stands at 170.0 days, suggesting that working capital remains tied up for a relatively long operating cycle.
DSO increased by +2.2 days, pointing to slower receivables turnover.
Working Capital Efficiency
TTM YoY · 2025Q1 -> 2026Q1
Is financial risk significant?
Leverage is safe but FCF is negative at 117.0bn due to capex of 41.1bn — an investment choice, not an urgent risk.
Leverage & Liquidity
Leverage looks fairly comfortable, with net debt / equity at 0.25x and interest coverage at 4.40x.
At present, short-term debt accounts for 91.7% of total debt, cash equals 4.5% of debt, and total debt stands at 368.6bn.
Watchpoints
Short-term debt accounts for 91.7% of total debt, raising near-term refinancing needs.
Cash / debt stands at 4.5%, leaving limited liquidity buffer to monitor.
Leverage and liquidity trend
TTM YoY · 2025Q1 -> 2026Q1
Cash Flow
With safe leverage noted above, cash flow below shows the self-funding capacity. Operating cash flow reached 19.1bn in 2025, against investing cash flow of -21.8bn.
Post-investment cash flow was negative +2.6bn. Financing cash flow was positive +6.0bn.
CFO / net income was -0.80x.
After spending +41.1bn on fixed-asset investment, the business generated trailing free cash flow of −117.0bn.
Cash Conversion
TTM Cash Conversion · 2025Q1 -> 2026Q1
Investment Takeaway
The business is heading the right way, but the current picture is still at partial confirmation — not yet a fully clean case. The positive points have clearly improved, showing the operating base is better than before. The brighter spot is operating efficiency, with net margin improving 6.1 pp. The main risk still sits in leverage and liquidity, with interest coverage at 4.40x.
Improvement: operating efficiency is getting better, with trailing-12M net margin at 15.07% after expanding 6.1pp versus the same period last year.
Key risk: leverage and liquidity remain a pressure point, with net debt / equity at 0.25x and a thin cash buffer.
Statement Data
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
|
Net Revenue
|
616.9 | 535.1 | 454.1 | 200.6 |
|
Cost of Goods Sold
|
485.7 | 457.0 | 372.9 | 163.3 |
|
Gross Profit
|
131.2 | 78.0 | 81.2 | 37.3 |
|
Financial Expenses
|
27.0 | 22.8 | 12.0 | 1.5 |
|
Selling Expenses
|
11.4 | 10.1 | 15.7 | 4.3 |
|
General and Administrative Expenses
|
14.4 | 11.8 | 9.8 | 8.0 |
|
Operating Profit
|
116.0 | 60.8 | 58.2 | 33.2 |
|
Profit Before Tax
|
119.4 | 60.7 | 65.8 | 32.9 |
|
Net Income
|
95.8 | 48.5 | 52.7 | 26.1 |
|
Profit Attributable to Parent
|
95.8 | 48.5 | 52.7 | 26.1 |
|
Earnings per Share
|
913.00 | 462.00 | 502.00 | 130.00 |
Explore Other Stocks In The Same Sector
VCS, VLB, HT1, MVC, THG, KSB, NNC, LBM, FIC, DHA, LIC, HUB, VIT, MTA, TLD, SCL, PDB, CVT, MDG, CLH, RYG, QNC, BTS, CMD, HCC, S74, VHL, PCC, YBM, VCX, CCM, C32, BCC, GND, HOM, TRT, TLT, BTD, TNT, FCM, GMH, GMX, ACE, KHD, SCJ, VIH, CDG, CQT, BDT, YBC, AMC, SDY, KSQ, NHC, EME, TMX, TAB, XMD, TDF, DDB, DAC, MCC, HMR, TTC, NXT, DID, TCR, DIC, MIC, VIM, DXV, VTS, HPM, TXM, SCC, DCR, DKG, LMC, GKM, BHC, TTZ, X77, LQN, VHH, SPI, BTN, HLY, DGT, VTA, CMI, DTC, DND, ILA, CYC, LCC, PTE, HVX, BT6, DCT, CTA, KHL, PX1
Need support? If you need support with content lookup or want to provide feedback about content on the website, please contact us below.